• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Light-Responsive Nanomaterials for Cancer Therapy

    2022-08-17 01:51:08XuZhngShengWngGuohuiChengPengYuJinChng
    Engineering 2022年6期

    Xu Zhng, Sheng Wng,*, Guohui Cheng, Peng Yu, Jin Chng,b,*

    a School of Life Sciences, Tianjin University, Tianjin 300072, China

    b Tianjin Engineering Center of Micro–Nano Biomaterials and Detection–Treatment Technology, Tianjin 300072, China

    Keywords:Light-responsive Nanomaterials Cancer Phototherapy

    ABSTRACT Due to its unique advantages,which include minimal invasiveness and relative clinical safety,phototherapy is considered to be a promising approach for cancer treatment. However, the treatment efficacy of phototherapy is often restricted by the limited depth of light penetration and the low targeting effect of phototherapeutic agents.The emergence of light-responsive nanomaterials offers a possible approach to achieve enhanced phototherapy potency.This review summarizes the progress in biomedical applications of light-responsive nanomaterials for cancer therapy, which include photothermal therapy (PTT),photodynamic therapy(PDT),light-responsive molecule delivery,and light-controlled combination therapy. Future prospects are also discussed. This review aims to demonstrate the significance of lightresponsive nanomaterials in cancer therapy and to provide strategies to expand the applications of phototherapy.

    1. Introduction

    In recent years,phototherapy has received a great deal of attention due to its advantages of spatiotemporal addressability, minimal invasiveness, and relative clinical safety [1,2]. As early as 1903, Niels Ryberg Finsen—the founder of modern phototherapy—was awarded the Nobel Prize for treating a skin disease(lupus vulgaris) using sunlight and ultraviolet (UV) radiation[3,4]. Since then, phototherapy has been continuously developed in biomedical engineering to combat skin diseases (e.g., eczema,psoriasis, and itchy skin) and mood and sleep disorders (e.g., seasonal affective disorder[5,6],non-seasonal depression[7],and circadian rhythm sleep disorders [8]). With the aid of phototherapeutic agents, such as photosensitizers and photothermal conversion agents (PTCAs), phototherapy has also proved to be an effective approach to ablate tumors [9].

    Light sources that are commonly applied in cancer phototherapy include UV light (100–400 nm), visible light (400–760 nm),and near-infrared (NIR) light (760–1350 nm). However, due to the absorption of biological tissues, the widely used UV light and visible light have limited tissue penetration depth [10], which restricts traditional phototherapy to superficial tumors and may lead to the risk of relapse and metastasis [1,11]. In addition, low targeting efficiency caused by the nonspecific distribution of phototherapeutic agents is an important issue that must be addressed.Untargeted delivery of phototherapeutic agents in therapy procedures will not only lead to low bioavailability and poor efficacy,but also cause side effects.

    With the development of nanotechnology, various phototherapeutic nanoagents based on versatile nanomaterials have been exploited to overcome the abovementioned limitations in cancer phototherapy [12–14]. Nanoagents with a specific size range(20–200 nm) accumulate in tumor tissue due to the enhanced permeation and retention (EPR) effect [15–17]. Therefore, nanomaterials hold potential to serve as carriers to deliver therapeutic molecules such as photosensitizers, PTCAs, drugs, and genes to tumor tissue, thereby achieving targeted therapy and combination therapy [18–20]. In order to address the issue of limited light penetration depth in phototherapy, NIR-light-responsive nanomaterials have been developed. For example, PTCAs that can directly absorb NIR light and generate heat have been used for NIR-triggered photothermal therapy (PTT). Upconversion nanoparticles (UCNPs), which can absorb long-wavelength NIR light and emit specific short-wavelength UV or visible light, have been used as a transducer to realize deeper penetration [21,22].Thus, light-responsive nanomaterials offer the possibility of overcoming the obstacles in and expanding the applications of phototherapy.

    In this review, we summarize recent advances in lightresponsive nanomaterials for cancer therapy (Table 1 [23–47]).These nanomaterials can be applied in PTT,photodynamic therapy(PDT), light-responsive molecule delivery, and light-controlled combination therapy (Fig. 1). We also discuss current challenges and prospects in phototherapy. The purpose of this review is to emphasize the significant role of light-responsive nanomaterials in cancer phototherapy and to provide further directions to expand their applications.

    2. Light-responsive nanomaterials

    Light-responsive nanomaterials that are used in cancer phototherapy include PTCAs,nanophotosensitizers,and nanoplatforms containing light-responsive moieties. PTCAs are agents that can capture light energy and convert it into heat to trigger cancer cell death. In general, PTCAs can be divided into two categories:organic materials and inorganic materials. Common organic PTCA materials include organic dye molecules (e.g., indocyanine green(ICG)) and organic nanoparticles (NPs) (e.g., semiconducting polymer NPs) [48,49]. Inorganic PTCA materials include noble metal materials (e.g., gold (Au) nanomaterials), transition metal chalcogenides and oxides (e.g., copper sulphide (CuS) NPs), and carbonbased materials (e.g., graphene oxide) [50].

    Photosensitizers can be activated by light with a specific wavelength to generate reactive oxygen species(ROS)and damage cancer cells through local oxidative stress [51]. Photosensitizers can also be divided into organic materials and inorganic materials.Organic photosensitizers include organic dye molecules such as porphyrin and boron-dipyrromethene (BODIPY), while inorganic photosensitizers include titanium dioxide (TiO2), zinc oxide(ZnO), graphitic carbon nitride (g-C3N4), and more [52,53].

    Table 1 Summary of light-responsive nanomaterials in cancer therapy.

    Fig. 1. Schematic illustration of applications of light-responsive nanomaterials in cancer therapy. NPs: nanoparticles.

    Many light-responsive nanoplatforms have been designed and developed by exploiting light-responsive linkers, such as azobenzene[54].These nanoplatforms can be used as efficient nanocarriers to realize light-responsive molecule delivery. In addition to designing such nanoplatforms to directly respond to light, lightresponsive nanomaterials can be designed to respond via a cascade strategy[55].For example,nanomaterials composed of photothermal agents (PTAs) and thermal-sensitive linkers can respond to light irradiation. Moreover, light-induced ROS generation can lead to the cleavage of some chemical bonds,such as thioketal(TK)linkers, thereby achieving light-triggered drug release [56].

    3. Photothermal therapy

    PTT is a promising treatment with minimal invasiveness and high therapeutic effects in cancer therapy [57]. Under irradiation by external light, PTCAs absorb light energy and convert it into heat, which kills cancer cells. PTCAs usually need to have high NIR absorption and high photothermal conversion efficiency. In the past decades, various nanomaterial-based PTCAs, such as Au nanomaterials, black phosphorus (BP), niobium carbide, graphene,metallic/nonmetallic compounds, and organic dye, have been developed for PTT [23–26,58–60]. For example, El-Sayed et al.[61] reported that gold nanorod (GNR)-assisted plasmonic PTT is a potential and effective alternative to traditional surgery.Furthermore,GNR PTT can decrease the collective migration of cancer cells by regulating and remodeling actin filaments and cell junction proteins [62]. De Sio et al. [27] reported a keratin-coated biomimetic gold NP (Ker-AuNP) that can be used as a highly efficient PTCA for plasmonic PTT.

    Zhang et al. [28] developed an inorganic nanotheranostic agent (Gd:CuS@bovine serum albumin (BSA) NPs) based on gadolinium (Gd)-integrated copper sulphide (CuS) NPs (Fig. 2(a)). Due to the strong NIR absorbance of the Gd:CuS NPs [63–65] and the good biocompatibility achieved by the BSA modification [66], the nanotheranostic agent (Gd:CuS@BSA NPs) can be used as an excellent nanotheranostic agent for in vivo photoacoustic (PA)/magnetic resonance imaging (MRI) guidance and effective PTT. As shown in Fig. 2(b), under NIR laser irradiation,the temperature of the Gd:CuS@BSA NPs clearly increased, indicating the good photothermal effect of Gd:CuS. Moreover, the Gd:CuS@BSA NPs exhibited the continuous enhancement of in vivo PA/MRI signals within 24 h on tumor-bearing mice(Fig. 2(c)). Dual-modal imaging facilitated imaging-guided phototherapy, resulting in potent tumor elimination. To verify the PTT effect of the Gd:CuS@BSA NPs in vitro, a cytotoxicity study and live/dead cell co-staining were carried out on SK-OV-3 cells.As shown in Figs. 2(d) and (e), the relative viabilities of the tumor cells were obviously decreased upon laser irradiation,which demonstrated the tumor-ablation effect of Gd:CuS@BSA.The photothermal effect of Gd:CuS@BSA was also demonstrated in vivo. As shown in real-time thermal images (Fig. 2(f)), when treated with Gd:CuS@BSA NPs, the temperature of the tumor sites increased by 21°C, which was significantly higher than the temperature increase in the control group (6°C). Under NIR laser irradiation, the tumor exhibited remarkable regression, followed by complete elimination (Fig. 2(g)), which demonstrated the significant tumor-ablation effect of PTT.

    Apart from inorganic nanomaterials, organic nanoagents play essential roles in cancer PTT. For example, US Food and Drug Administration (FDA)-approved ICG, a highly biocompatible NIR organic dye, has been widely applied in PTT due to its various energy level transition pathways upon NIR light excitation[67,68]. In addition, Pu et al. [29] reported semiconducting polymer nanoenzymes (SPNs) with an NIR photothermic effect for enhanced cancer therapy. As shown in Fig. 3(a), the SPNs contain a semiconducting polymer amphiphile (PCB) as a photothermal nanotransducer and bromelain (Bro) as a temperature-sensitive enzyme. Under NIR laser irradiation, the local temperature increased due to the photothermal conversion activity of the SPNs,leading to the photothermic activation of Bro. Therefore, collagen,the most abundant protein in the tumor extracellular matrix [69],was digested in situ,resulting in the improved tumor accumulation of SPNs and enhanced PTT.Upon 808 nm laser irradiation,the temperatures of the PCB1-Bro group were obviously increased, both in vitro (Fig. 3(b)) and in vivo (Fig. 3(c)), which verified the high photothermal conversion efficiency of PCB1-Bro. Moreover, the penetration depth of PCB1-Bro with NIR laser irradiation was evidently enhanced in comparison with the penetration depth without laser irradiation, confirming that photothermal-enhanced collagen digestion had occurred. As shown in Fig. 3(d), after the photothermic activation of the Bro enzyme,the tumor fluorescence signals of the PCB1-Bro-treated group were higher than those of other groups, indicating enhanced tumor accumulation of PCB1-Bro due to collagen digestion. The efficient accumulation of PCB1-Bro further led to a higher tumor temperature and stronger tumor growth inhibition (Figs. 3(c) and (e)).

    Fig.2. (a)Schematic illustration of Gd:CuS@BSA hybrid theranostic agents for imaging-guided tumor PTT.MRI:magnetic resonance imaging.(b)Infrared thermal images of an aqueous Gd:CuS@BSA NPs droplet of a Gd:CuS@BSA NP and a deionized water droplet with NIR laser irradiation(980 nm).(c)PA/MRI(dual-modal imaging)of an SK-OV-3 tumor before and after Gd:CuS@BSA treatment. (d)Viability of SK-OV-3 cells treated with Gd:CuS@BSA NPs and laser irradiation (980 nm, 0.6 W?cm-2,5 min).Ctrl: control group(treated with 0 μg?mL-1 Gd:CuS@BSA NPs).(e)Fluorescence staining of live/dead SK-OV-3 cells after treatment with different formulations.(f)In vivo thermal imaging of an SK-OV-3 tumor treated with different formulations followed by laser irradiation (980 nm, 5 min). (g) Growth curves of an SK-OV-3 tumor treated with different formulations. Reproduced from Ref. [28] with permission of American Chemical Society, ? 2016.

    Due to the advantages of PTT,some PTCAs have already entered clinical trials. In 2019, the results of a phase I trial demonstrated the feasibility of an approach involving gold–silica nanoshells for the focal PTT ablation of prostate tumors[70].In addition,in order to further improve the light penetration depth, NIR-II lightresponsive PTCAs have gained increased research attention. For example, Yang et al. [71] developed a polyethylene glycol-graftpolyethylenimine-modified hollow carbon nanosphere for NIR-II laser-activated cancer PTT.

    4. Photodynamic therapy

    PDT is a clinically approved modality that has been used for more than 40 years in the treatment of cancers, including superficial skin lesions, esophageal tumors, and lung tumors [48]. There are three essential elements in PDT: oxygen, a photosensitizer,and light [72]. Hundreds of photosensitizers have been applied for PDT clinically or preclinically, including porphyrin, chlorin,and phthalocyanine derivatives[73,74].In a conventional PDT process, photosensitizers transfer light energy to surrounding molecules to generate cytotoxic ROS for cancer treatment [75–77].There are two main types of photodynamic reaction—type I and type II. In the mechanism of a type I reaction, a triplet-state photosensitizer reacts with cellular substrates directly via electron transfer,resulting in the generation of free radicals.The generated radicals then react with oxygen (O2) to produce oxygenated products, including superoxide anions (O2-), hydrogen peroxide(H2O2),and hydroxyl radicals (·OH). Alternatively, in the mechanism of a type II reaction, a triplet photosensitizer transfers energy directly to oxygen (3O2) to produce highly reactive singlet oxygen (1O2)[14,73,76]. Most of the existing PDT systems adopt the oxygendependent type II mechanism [78].

    Fig. 3. (a) Schematic illustration of PCB1-Bro for photothermally enhanced NP accumulation in tumors. EDC/NHS: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/Nhydroxysuccinimide. (b) Temperature changes of different samples upon laser irradiation. (c) Infrared thermal images of 4T1 tumor-bearing mice treated with different formulations and laser irradiation (808 nm, 5 min). (d) Real-time fluorescence images of 4T1 tumor-bearing mice treated with different formulations with/without laser irradiation. (e) Growth curves of a 4T1 tumor with different treatments. PBS: phosphate buffered saline. Reproduced from Ref. [29] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2018.

    Compared with other conventional therapeutic methods, PDT possesses several advantages, including minimal invasiveness, the spatial accuracy of the operation, minimal side effects, non-drug resistance, and a short recovery period [79]. However, PDT also has major restrictions,including the hypoxic condition of the tumor,the low targeting efficiency of the photosensitizer,and limited light penetrationdepth.In addition,the nonspecific distributionof photosensitizers causes phototoxicity in normal tissues, which must be taken into consideration. Due to stringent requirements regarding biocompatibility and the frontier orbitals of the molecular motifs,the choice of efficient molecular photosensitizers remains limited[30].To address these problems,many novel photosensitizers with versatile properties have been developed to enhance the efficacy of PDT. For example, porous covalent organic frameworks (COFs)with excellent ROS production efficiency have been developed by linking ROS-inert molecular motifs [30]. To enhance the effects of PDT in deep tissues, a combination of UCNPs and photosensitizers is an efficient approach[80].Xing et al.[81]proposed a strategy to achieve highly efficacious PDT by integrating UCNPs with graphene quantum dots(GQDs).UCNPs can serve as light transducers to convert NIR light into visible light for photosensitizer activation, thus greatly expanding the applicability of PDT.

    Moreover, some studies have demonstrated that the radicals generated via a type I photoreaction can amplify PDT response,especially under hypoxic conditions [82]. Based on this, Yoon et al. [83] reported a nanostructured phthalocyanine assembly(NanoPcA), which has a favorable antibacterial effect through enhanced type I PDT. Jiang et al. [31] developed a type I nanoagent—namely, dihydrolipoic-acid-coated gold nanoclusters(AuNC@DHLA)—for two-photon anticancer PDT.In this nanoagent,Au nanoclusters are used as a promising photosensitizer due to their excellent biocompatibility and long fluorescence tripletstate lifetime [84]. In another study, Lin et al. [32] reported a nanoscale metal–organic framework (NMOF) based on 5,10,15,20-tetra (p-benzoato) bacteriochlorin (TBB) ligands(denoted as Zr-TBB) for enhanced PDT via both type I and type II mechanisms(Fig.4(a)).As a nanophotosensitizer,NMOF possesses the unique properties of high photosensitizer loading efficacy, a porous structure, and intrinsic biodegradability[85].Bacteriochlorin exhibits excellent absorption in the NIR region (700–850 nm)and can be used for type I PDT under hypoxic conditions [86].However, the PDT efficacy of bacteriochlorin is significantly restricted by its instability to oxygen and light [87,88]. The structure of NMOF is beneficial for stabilizing bacteriochlorin’s ligands,thereby preventing unimolecular photodecomposition and selfquenching. As shown in the confocal laser scanning microscopy(CLSM) images in Fig. 4(b), four types of ROS (O2-, H2O2,·OH, and1O2) were produced in the Zr-TBB group, confirming the presence of light-induced type I and type II PDT processes. Accordingly,Zr-TBB exhibits excellent in vivo antitumor efficacy against both subcutaneous 4T1 and MC38 tumors (Fig. 4(c)).

    Traditional photosensitizers, such as porphyrin derivatives, are hydrophobic and tend to aggregate in aqueous solution.The aggregation state of photosensitizers causes fluorescence quenching,which reduces the ROS production efficiency and greatly limits the PDT treatment outcome [89,90]. To address this issue, Chen et al.[91]developed a single molecular nanophotosensitizer based on a porphyrin nanocage. Due to the rigid structure of the nanocages, the π–π stacking interaction between the photosensitizers is inhibited, which promotes the photosensitizing effect.

    The development of aggregation-induced emission(AIE)photosensitizers provides another strategy to overcome the quenching effect of traditional photosensitizers [92,93]. Recently, Tang et al.[33]proposed a ‘‘1 + 1 +1 >3” synergistic strategy based on three AIE luminogens(AIEgens).The AIEgens have the same photosensitizer backbone but different targeting groups that can target mitochondria, the cell membrane, and lysosomes, respectively (Fig.5(a)). As shown in Fig. 5(b), after cellular uptake by 4T1 cells, the three AIEgens manifested excellent co-localization with corresponding organelles. The tumor-inhibition effect of this three-inone group was found to be better than that of each photosensitizer alone, which was ascribed to the synergistic PDT strategy (Fig.5(c)).

    Due to the nonspecific biodistribution of photosensitizers,most photosensitizers will trigger phototoxicity when patients are exposed to sunlight. To reduce the phototoxicity, activatable PDT is a promising strategy. For example, Li et al. [34] developed an AIE-photosensitizer-loaded liposome (AIE-PS@liposome) to achieve controlled photosensitization. As shown in Fig. 5(d), the photosensitivity of the AIE-PS entrapped in the lipid bilayer is in an ‘‘OFF” state; however, once the AIE-PS@liposomes reach tumor sites, the AIE-PS are released for in situ reaggregation, leading to activated PDT.As expected,the AIE-PS@liposomes exhibited much lower phototoxicity under both laser and sunlight irradiation in comparison with the control groups, which included AIE-PS nanoaggregates and the commercial photosensitizer chlorin e6(Ce6) (Fig. 5(e)).

    5. Light-responsive molecule delivery

    The low targeting of therapeutic agents in cancer therapy results in unsatisfactory efficacy and severe side effects in normal tissues. With the development of stimuli-responsive delivery systems, an increasing number of nanocarriers based on polymeric and inorganic nanomaterials have been exploited to realize the targeted delivery of drugs, photosensitizers, genes, and so forth [94–98]. As an external stimulus, light has unique features for controlling the release behaviors of therapeutic agents at precise locations and avoiding individual variability [35,99]. For example, thermalresponsive nanomaterials can achieve light-triggered drug delivery via photothermal-induced linker cleavage, structural changes in nanocarriers, radical generation, and other pathways [36–39].The ROS produced by photosensitizers under light irradiation can also lead to on-demand drug delivery by triggering the cleavage of ROS-sensitive linkers, such as TK linker [40,100].

    Fig.4. (a)Schematic illustration of bacteriochlorin ligands stabilized in Zr-TBB for type I and type II PDT.(b)CLSM images of ROS generation in 4T1 cells treated with different formulations after light irradiation.Scale bars:20 μm.(c)Growth curves of a 4T1 tumor and an MC38 tumor treated with different formulations.Reproduced from Ref.[32]with permission of American Chemical Society, ? 2020.

    Fig. 5. (a) Chemical structures and schematic illustration of three AIEgens for synergistically enhanced PDT. (b) Co-localization of the AIEgens in CLSM images of 4T1 cells treated with different formulations.(c)Growth curves of a 4T1 tumor treated with different formulations.(d)Schematic illustration of AIE-PS@liposomes for activatable PDT.DSPE-PEG: distearoylphosphatidylethanolamine-poly(ethylene glycol) 2000; DMPC: 1,2-dimyristoyl-sn-glycero-3-phosphocholine. (e) Blood vessels in ears treated with different formulations. (a)–(c) Reproduced from Ref. [33] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2020; (d) and (e) reproduced from Ref. [34] with permission of American Chemical Society, ? 2019.

    Liang et al. [41] developed diazirine (DA)-decorated human serum albumin (HSA) nanomedicines (denoted as HSA dNMs) for the co-encapsulation of photosensitizer(ICG)and the prodrug tirapazamine (TPZ) via electrostatic and hydrophobic interactions(Fig. 6(a)). As shown in Fig. 6(b), under 405 nm laser irradiation,the DA groups transformed into reactive carbine moieties and reacted with the adjacent HSA dNMs for crosslinking, leading to improved tumor accumulation and retention of ICG/TPZ@HSA dNMs. Next, 808 nm laser irradiation triggered hyperthermia and ROS generation for tumor PTT and PDT. In addition, the oxygen consumption in the PDT process led to hypoxia aggravation and TPZ activation to achieve synergistic therapy. The lightresponsive delivery of HSA dNMs was confirmed by both in vitro and in vivo results.The size of the HSA dNMs with DA modification was clearly increased after exposure to a laser at 405 nm(Fig.6(c)),which verified the UV-light-triggered aggregation behavior. The tumor accumulation of the ICG/TPZ@HSA dNMs in vivo was represented by the imaging contrast index (CI) calculated from the fluorescent signal ratio of tumor to tissue [101]. The CI values of the UV-laser-treated group were significantly higher than those of the control group without laser irradiation, confirming the laserenhanced tumor accumulation behavior of the ICG/TPZ@HSA dNMs(Fig. 6(d)).Consistent results were obtained,based on biodistribution fluorescence images. As shown in Fig. 6(e), the fluorescence intensity of the tumors was significantly increased after laser treatment. This elaborate design of ICG/TPZ@HSA dNMs enhanced the targeted delivery of ICG/TPZ and improved the anticancer efficacy through light-induced aggregation and cascade phototherapy/chemotherapy.

    Aside from the delivery of drugs and photosensitizers,nanomaterials can be applied for the light-controlled selective activation of gene expression in gene therapy. For example, optogenetics is a combination of optical and genetic methods to precisely control the expression of proteins in specific cells,so as to control intracellular biological processes and behaviors [102]. Like most lighttriggered delivery systems that rely on UV/visible light irradiation,the activation of the photo-actuator in optogenetics is seriously restricted by the limited light penetration depth [103–105]. To address this issue, UCNPs can serve as a nanotransducer to transform external NIR light with deep penetration depth into local UV/visible light for the noninvasive activation of photoreceptors in vivo [106,107].

    Fig.6. Light-responsive drugs/photosensitizers delivery system for cancer therapy.(a)Schematic illustration of ICG/TPZ@HSA dNMs for cascaded synergistic cancer therapy triggered by laser irradiations(405 and 808 nm).CT:chemotherapy.(b)Scheme of 405 nm laser-induced aggregation of ICG/TPZ@HSA dNMs.(c)Size changes of HSA dNMs with different sequential laser irradiation times. (d) Tumor accumulation of ICG/TPZ@HSA dNMs, as represented by CI values. (e) In vivo biodistribution of ICG/TPZ@HSA dNMs in 4T1 tumor-bearing mice. T/N: the fluorescence signal ratio of tumor to tissue; p.i.: postinjection. Reproduced from Ref. [41] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2018.

    Chang et al. [108] developed an upconversion optogenetic nanosystem composed of UCNPs, arabidopsis flavoprotein cryptochrome 2 (Cry2), and its interacting partner Cib1 plasmids. The UCNPs play a part in both plasmid DNA (pDNA) delivery and light transformation. External NIR-light-triggered local blue light emitting noninvasively induces photoreceptor Cry2 and Cib1 interaction, which activates the apoptotic signaling pathway of cancer cells. In another effort, Chang’s group [35] reported on an NIRcontrolled gene-delivery system based on mesoporous silica(mSiO2)@polyethyleneimine (PEI) nanocarrier-conjugated upconverting rods (UCRs) (Fig. 7(a)). Upon NIR light irradiation, the external NIR light is converted into UV light by the UCRs to trigger the cleavage of o-nitrobenzyl groups (Fig. 7(b)). As a result, the gene-loaded mSiO2@PEI nanocarriers are released for gene delivery(Fig.7(c)).This gene expression study reported that the genes were released and expressed upon NIR irradiation,confirming that lightcontrolled precisely regulated gene expression at high spatial and temporal resolutions had been achieved.

    6. Light-controlled combination therapy

    Although phototherapy techniques have been developed in recent years,some drawbacks of single-mode phototherapy,which relies on only one therapeutic method,remain to be resolved,such as relapse or metastasis in the treatment of persistent tumors [1].To address this issue, combination phototherapy with immunotherapy, gene therapy, chemotherapy, chemodynamic therapy (CDT), and other therapy methods can maximize the advantages of each therapeutic pattern and achieve complementary multitherapeutic efficacy [109,110].

    Photo-immunotherapy, which can eliminate primary tumors and induce host immunity in order to control distant metastases,is considered to be a promising strategy for the treatment of metastatic cancer [111]. For example, Wang et al. [42] developed an injectable red blood cell (RBC)-based gel for cancer photoimmunotherapy. After the subcutaneous injection of imiquimod(R837) adjuvant engineered RBCs, a hydrogel-like composition spontaneously formed due to the infiltrated platelets and thrombin. The photothermal effect of the in situ-formed RBC gel led to the photoablation of tumors and the production of tumorassociated antigens,thereby initiating adaptive immune responses to cancer.Moreover,the released immunoadjuvant,R837,induced robust and persistent immune responses for cancer metastasis/recurrence inhibition.

    Liang et al.[43]developed an‘‘a(chǎn)ll-in-one”theranostic nanomedicine based on CuInS/ZnS(ZCIS)quantum dots(QDs)for synergistic PTT/PDT therapy. QDs have been widely used in tumor diagnosis and treatment due to their high fluorescence intensity and broad excitation spectrum [44,112,113]. The efficient absorption effect of ZCIS QDs in the range of 650–750 nm has enabled noninvasive fluorescence/multispectral optical tomography imaging. Furthermore, the photothermal and photodynamic effects of ZCIS QDs could be used for cancer treatment (Fig. 8(a)).

    In addition,Chang et al.[45]reported a multifunctional nanotheranostic agent (PB@PEI/HSP70-p53-GFP NP) based on human HSP70 promoter-loaded Prussian blue (PB) nanocubes for NIR light-triggered PTT/gene combination therapy. As shown in Fig.8(b), due to the photothermal property of the PB nanocubes, the HSP70 promoter was activated under mild NIR laser irradiation(≈41°C),resulting in tumor suppressor p53-dependent apoptosis.Under strong NIR laser irradiation (≈50°C), both PTT and gene therapy were activated. Thus, the synergistic antitumor efficacy can be adjusted by the NIR laser irradiation.

    Fig. 7. Light-responsive gene delivery and expression. (a) Synthetic procedure for the mSiO2@PEI gene nanocarrier and the UCR substrate. APTES: 3-aminopropyl triethoxysilane;TEOS:tetraethyl orthosilicate;PAA:poly(acrylic acid).(b)Schematic illustration of the light-triggered release of mSiO2@PEI gene nanocarriers from the UCR substrate due to photocleavage of o-nitrobenzyl groups. (c) Fluorescence images of the substrate immobilized with rhodamine-loaded mSiO2@PEI nanocarriers with or without NIR laser (980 nm, 8.9 W?cm-2, 12 min). Reproduced from Ref. [35] with permission from Wiley-VCH Verlag GmbH & Co. KGaA, ? 2015.

    The combination of chemotherapy and phototherapy is another important approach to realize synergistic therapy. Qian et al. [46]developed an ROS-responsive prodrug delivery nanoplatform for a combination of chemotherapy and PDT. As shown in Fig. 8(c),the chemotherapeutic drug camptothecin(CPT)and the photosensitizer pyropheophorbide-a (PPa) were conjugated to methoxypolyethylene glycol (MPEG) to prepare a polyprodrug, which further self-assembled into nanomedicine. The fluorescent PPa precisely located the tumor site and guided laser irradiation. Next,the ROS generated from the PPa-mediated PDT process broke the ROS-responsive TK linker between the polymer and CPT, leading to controlled release of the CPT drugs. This combination of chemotherapy and PDT exhibited a more effective antitumor effect than monotherapy.

    Similar to PDT, CDT involves the generation of highly oxidative hydroxyl radicals for tumor treatment [114–117]. Tang et al. [47]constructed a programmed release system (NMOF@dihydroartemisinin (DHA)@calcium carbonate (CaCO3)) based on DHA-loaded ferrum(Fe)-(4,4,4,4-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)) (TCPP)NMOF with CaCO3mineralized coating(Fig.8(d)).The weak acidity of the tumor microenvironment led to the dissolution of the CaCO3layer, resulting in Ca2+release. Once the NMOF@DHA entered cancer cells, the high glutathione (GSH)level inside the cells led to Fe3+reduction and TCPP activation,due to NMOF skeleton collapse. Therefore, NMOF@DHA@CaCO3was able to realize Ca2+-DHA-mediated oncosis therapy, Fe2+-DHA-mediated CDT, and TCPP-mediated PDT.

    7. Conclusions and future perspectives

    Light-induced phototherapy has been widely used to combat cancers due to its minimal invasiveness and minor side effects[118]. However, the efficacy of phototherapy is restricted by the limited depth of light penetration and the untargeted distribution of phototherapeutic agents. The emergence of light-responsive nanomaterials provides a promising approach to address these issues due to the specific properties of such nanomaterials, which include their nanoscale size,multifunctional surface modifications,and controllable synthesis.As a result,enhanced phototherapy has been achieved through the rational design of light-responsive nanomaterials.

    This review summarized recent advances in light-responsive nanomaterials for cancer therapy, including PTT, PDT, lightresponsive molecule delivery, and light-controlled combination therapy. To achieve precise cancer phototherapy and accelerate clinical transformation, the following aspects should be taken into consideration:

    (1) Limitation of light penetration depth. The penetration depth of light relies on the light wavelength. UV light and visible light are mainly applied in the treatment of superficial skin diseases due to their limited penetration depth. In addition, light is attenuated to a large extent when it interacts with tissues, which hinders the applications of phototherapy, especially in the treatment of deep-tissue tumors. Although the application of UCNPs provides an approach to increase light penetration depth, UCNPs still have the disadvantage of low conversion efficiency.Compared with the NIR-I window(750–1000 nm),the NIR-II window(1000–1350 nm) exhibits reduced light scattering, minimized tissue absorption,and higher maximum permissible laser exposure;thus,it seems to be a prospective candidate for achieving deep-tissue penetration depth [119,120]. Therefore, NIR-II-responsive nanomaterials show great potential for expanding the application of phototherapy.

    Fig.8. Light-controlled combination cancer therapy.(a)Schematic illustration of ZCIS QDs in the combination therapy of PTT and PDT.FL:fluorescence;MSOT:multispectral optoacoustic tomography; US: ultrasound;ΔT: temperature increase. (b) Schematic illustration of PB@PEI/HSP70-p53-GFP NPs in the combination therapy of gene therapy and PDT. (c) Schematic illustration of MPEG–(TK–CPT)–PPa in the combination therapy of chemotherapy and PDT. (d) Schematic illustration of NMOF@DHA@CaCO3 in the combination therapy of CDT and PDT.(a)Reproduced from Ref.[43]with permission of American Chemical Society,?2016;(b)reproduced from Ref.[45]with permission of Wiley-VCH Verlag GmbH&Co.KGaA,?2018;(c)reproduced from Ref.[46]with permission of Wiley-VCH Verlag GmbH&Co.KGaA,?2020;(d)reproduced from Ref.[47]with permission from Wiley-VCH Verlag GmbH & Co. KGaA, ? 2019.

    (2) Risk of potential toxicity. In the light-triggered molecule delivery process of phototherapy, the uncontrolled burst release of drugs from nanocarriers leads to short-term toxicity,while slow and incomplete metabolism of nanomaterials may result in longterm toxicity [121]. Furthermore, the untargeted biological distribution of light-responsive nanotherapeutic agents may cause sunlight-exposure-induced systemic toxicity. In order to realize precise controllable cancer phototherapy, an ideal nanomedicine should only be activated at the tumor site, and should maintain an ‘‘OFF” state in normal tissues. Therefore, the development of activatable phototherapeutic agents that can respond to the typical characteristics of the tumor microenvironment is an effective way to address the issue of phototoxicity.

    (3)Clinical transformation.In order to achieve multifunctional cancer therapy, nanomaterials are usually complex in both design and composition, which undoubtedly introduces difficulties into their clinical transformation. In addition, due to the unknown toxicity mechanism of some newly developed nanomaterials, the clinical application of these nanomaterials requires complex toxicity-assessment procedures.

    Acknowledgments

    This work was supported by the National Natural Science Foundation of China (32000991 and 51873150), the Young Elite Scientists Sponsorship Program by Tianjin (TJSQNTJ-2020-02), the Key Project of Tianjin Foundational Research(Jing–Jin–Ji)Program(19JCZDJC64100), and the Tianjin Research Innovation Project for Postgraduate Students (2020YJSB130).

    Compliance with ethics guidelines

    Xu Zhang, Sheng Wang, Guohui Cheng, Peng Yu, and Jin Chang declare that they have no conflict of interest or financial conflicts to disclose.

    国产亚洲av片在线观看秒播厂 | 免费黄色在线免费观看| 九九爱精品视频在线观看| 联通29元200g的流量卡| 国产熟女欧美一区二区| 国产精品av视频在线免费观看| 日本av手机在线免费观看| 中文乱码字字幕精品一区二区三区 | 免费黄频网站在线观看国产| 欧美不卡视频在线免费观看| 久久精品夜夜夜夜夜久久蜜豆| 舔av片在线| 在线免费十八禁| 亚洲人成网站高清观看| av.在线天堂| 精品久久久久久电影网| 91久久精品国产一区二区成人| 麻豆av噜噜一区二区三区| 人人妻人人看人人澡| 91久久精品电影网| 精品一区在线观看国产| 在线免费十八禁| 黄色欧美视频在线观看| 精品人妻偷拍中文字幕| 淫秽高清视频在线观看| 麻豆精品久久久久久蜜桃| 啦啦啦韩国在线观看视频| 肉色欧美久久久久久久蜜桃 | 国产成人a∨麻豆精品| 久久草成人影院| 中文字幕av在线有码专区| 久久精品国产亚洲av涩爱| av在线观看视频网站免费| 国产精品日韩av在线免费观看| 亚洲精品日本国产第一区| 一级爰片在线观看| 成人毛片a级毛片在线播放| 一级毛片 在线播放| 一个人观看的视频www高清免费观看| 美女高潮的动态| 国产成人a区在线观看| 久久久久久久久久人人人人人人| 黄片wwwwww| 欧美一区二区亚洲| 中文字幕亚洲精品专区| 国产精品1区2区在线观看.| 黄片wwwwww| 欧美激情在线99| 亚洲av不卡在线观看| 久久鲁丝午夜福利片| 美女大奶头视频| 午夜亚洲福利在线播放| 99热这里只有精品一区| 肉色欧美久久久久久久蜜桃 | 亚洲精品久久久久久婷婷小说| 少妇的逼好多水| 亚洲精品成人久久久久久| av免费在线看不卡| 国产淫片久久久久久久久| 亚洲av成人精品一区久久| av.在线天堂| 五月玫瑰六月丁香| 最近的中文字幕免费完整| 小蜜桃在线观看免费完整版高清| 亚洲精品日韩在线中文字幕| 国产精品爽爽va在线观看网站| 国产麻豆成人av免费视频| 少妇的逼水好多| 午夜日本视频在线| 久久97久久精品| 晚上一个人看的免费电影| 久久鲁丝午夜福利片| 久久精品国产自在天天线| 国产高清有码在线观看视频| 亚洲图色成人| 成人毛片a级毛片在线播放| 97在线视频观看| 国产精品美女特级片免费视频播放器| 日日摸夜夜添夜夜添av毛片| 久久精品久久久久久噜噜老黄| 天天躁日日操中文字幕| 国产色婷婷99| 久久久午夜欧美精品| 搡老乐熟女国产| 啦啦啦啦在线视频资源| 国产精品一区二区三区四区免费观看| 菩萨蛮人人尽说江南好唐韦庄| 一区二区三区免费毛片| 啦啦啦韩国在线观看视频| 亚洲激情五月婷婷啪啪| 免费看美女性在线毛片视频| 伊人久久国产一区二区| av在线蜜桃| 国产精品日韩av在线免费观看| 麻豆精品久久久久久蜜桃| 内射极品少妇av片p| 美女主播在线视频| 老司机影院成人| 午夜免费观看性视频| 国内精品美女久久久久久| 91aial.com中文字幕在线观看| 免费在线观看成人毛片| 国产片特级美女逼逼视频| 人妻少妇偷人精品九色| 美女cb高潮喷水在线观看| 一本久久精品| 男人和女人高潮做爰伦理| 欧美 日韩 精品 国产| 又爽又黄a免费视频| 精品国内亚洲2022精品成人| 可以在线观看毛片的网站| 久久久久国产网址| 免费高清在线观看视频在线观看| 亚洲av.av天堂| 日韩成人av中文字幕在线观看| 亚洲人与动物交配视频| 97超视频在线观看视频| 亚洲熟妇中文字幕五十中出| av一本久久久久| 听说在线观看完整版免费高清| 国产亚洲最大av| av福利片在线观看| 十八禁网站网址无遮挡 | 国产日韩欧美在线精品| 亚洲国产日韩欧美精品在线观看| 白带黄色成豆腐渣| av在线观看视频网站免费| 一级a做视频免费观看| 久久人人爽人人爽人人片va| 91精品一卡2卡3卡4卡| 国产精品一区二区三区四区免费观看| 在线播放无遮挡| 成人亚洲欧美一区二区av| 91午夜精品亚洲一区二区三区| av播播在线观看一区| 九九在线视频观看精品| 日本欧美国产在线视频| 久久国内精品自在自线图片| 干丝袜人妻中文字幕| 一级av片app| 国产成人精品一,二区| 免费人成在线观看视频色| 国产成人一区二区在线| .国产精品久久| 午夜福利网站1000一区二区三区| 久久精品国产亚洲av天美| 国产在线男女| 一级毛片黄色毛片免费观看视频| 精品久久久久久久久亚洲| 男女边吃奶边做爰视频| 午夜老司机福利剧场| 国产中年淑女户外野战色| 老女人水多毛片| 国产精品一区二区三区四区免费观看| 亚洲乱码一区二区免费版| 久久久久久久久久黄片| 91在线精品国自产拍蜜月| 亚洲精品乱码久久久v下载方式| av.在线天堂| 国产视频首页在线观看| 亚洲国产精品国产精品| 2022亚洲国产成人精品| 少妇猛男粗大的猛烈进出视频 | 国产精品不卡视频一区二区| 日韩大片免费观看网站| 亚洲精品成人av观看孕妇| 亚洲,欧美,日韩| 2022亚洲国产成人精品| 深夜a级毛片| 国产成人a∨麻豆精品| 免费看美女性在线毛片视频| 69av精品久久久久久| a级毛色黄片| 青春草视频在线免费观看| 国产午夜精品论理片| 边亲边吃奶的免费视频| 日日撸夜夜添| 嫩草影院新地址| 日韩 亚洲 欧美在线| 又爽又黄a免费视频| 国产伦理片在线播放av一区| 色网站视频免费| 免费av毛片视频| 一个人免费在线观看电影| 亚洲天堂国产精品一区在线| 亚洲精品久久久久久婷婷小说| av卡一久久| 国产探花在线观看一区二区| 久久这里只有精品中国| 国产69精品久久久久777片| 最近中文字幕2019免费版| 国产一区二区亚洲精品在线观看| 日日啪夜夜爽| 少妇人妻一区二区三区视频| 精品人妻熟女av久视频| 高清午夜精品一区二区三区| 国产高清有码在线观看视频| 欧美高清成人免费视频www| 亚洲乱码一区二区免费版| 免费av毛片视频| 老女人水多毛片| 国产v大片淫在线免费观看| 黄色一级大片看看| 99久久精品热视频| 久久久久久久久久黄片| 国产淫片久久久久久久久| 国产伦精品一区二区三区四那| 纵有疾风起免费观看全集完整版 | 欧美精品国产亚洲| a级毛色黄片| 国产在视频线在精品| 黄色日韩在线| 97人妻精品一区二区三区麻豆| 久久久成人免费电影| 亚洲精品日本国产第一区| 乱码一卡2卡4卡精品| 三级经典国产精品| 精品久久久久久久久亚洲| 色综合站精品国产| 亚洲欧美中文字幕日韩二区| 成人美女网站在线观看视频| 中文天堂在线官网| 黑人高潮一二区| 久久久精品欧美日韩精品| 国产欧美另类精品又又久久亚洲欧美| 日本与韩国留学比较| 99热网站在线观看| 毛片一级片免费看久久久久| 精品99又大又爽又粗少妇毛片| 欧美激情久久久久久爽电影| 亚洲精品成人久久久久久| 女人十人毛片免费观看3o分钟| 国产单亲对白刺激| www.av在线官网国产| 老司机影院成人| 成人欧美大片| 高清日韩中文字幕在线| 18禁动态无遮挡网站| 日韩一本色道免费dvd| 亚洲婷婷狠狠爱综合网| 欧美+日韩+精品| 亚洲自偷自拍三级| 成人鲁丝片一二三区免费| 欧美日韩一区二区视频在线观看视频在线 | 亚洲色图av天堂| 精品久久久久久电影网| 国产91av在线免费观看| 国产精品无大码| 亚洲欧美中文字幕日韩二区| 国产有黄有色有爽视频| 成人特级av手机在线观看| 国产在视频线在精品| 中文欧美无线码| 国产精品久久久久久精品电影小说 | 国产精品国产三级国产专区5o| 欧美最新免费一区二区三区| 国精品久久久久久国模美| 国产激情偷乱视频一区二区| 亚洲av福利一区| 少妇熟女欧美另类| 午夜福利在线观看免费完整高清在| 日日干狠狠操夜夜爽| 国产激情偷乱视频一区二区| av又黄又爽大尺度在线免费看| 如何舔出高潮| 亚洲真实伦在线观看| 婷婷色综合www| 日本熟妇午夜| 精品久久国产蜜桃| 亚洲av免费高清在线观看| 免费人成在线观看视频色| 久久久成人免费电影| 国产一级毛片在线| 黄片无遮挡物在线观看| 国产中年淑女户外野战色| 亚洲国产高清在线一区二区三| 日本av手机在线免费观看| 美女被艹到高潮喷水动态| 男人舔女人下体高潮全视频| 欧美3d第一页| 久久久久久九九精品二区国产| 色播亚洲综合网| 国产伦一二天堂av在线观看| 国产男人的电影天堂91| 乱码一卡2卡4卡精品| 日韩伦理黄色片| 99热全是精品| 男女啪啪激烈高潮av片| 熟女人妻精品中文字幕| 天堂中文最新版在线下载 | 精品一区二区三区视频在线| 欧美日韩综合久久久久久| 一夜夜www| 精品一区二区三卡| 亚洲av免费在线观看| 狠狠精品人妻久久久久久综合| 国产精品国产三级专区第一集| 亚洲av免费高清在线观看| av天堂中文字幕网| 久久韩国三级中文字幕| 十八禁网站网址无遮挡 | 国产亚洲av片在线观看秒播厂 | 色网站视频免费| 色综合亚洲欧美另类图片| 国语对白做爰xxxⅹ性视频网站| 国产高清三级在线| 久久热精品热| 超碰av人人做人人爽久久| 国产精品蜜桃在线观看| .国产精品久久| 日韩av免费高清视频| 麻豆av噜噜一区二区三区| 女人久久www免费人成看片| 美女黄网站色视频| 一级黄片播放器| 国产成人freesex在线| 久久这里只有精品中国| 成年人午夜在线观看视频 | 精华霜和精华液先用哪个| 久久人人爽人人片av| 夜夜看夜夜爽夜夜摸| 女人十人毛片免费观看3o分钟| 看黄色毛片网站| 国产亚洲91精品色在线| 免费少妇av软件| 男女下面进入的视频免费午夜| 国产69精品久久久久777片| 日韩av不卡免费在线播放| 麻豆成人午夜福利视频| 国产免费福利视频在线观看| 国模一区二区三区四区视频| 在线a可以看的网站| 日日摸夜夜添夜夜爱| kizo精华| 色哟哟·www| 十八禁国产超污无遮挡网站| 亚洲自偷自拍三级| 国产色爽女视频免费观看| av国产免费在线观看| 久久99热6这里只有精品| 亚洲av国产av综合av卡| 简卡轻食公司| 两个人的视频大全免费| 精品一区二区三区视频在线| 纵有疾风起免费观看全集完整版 | 欧美激情久久久久久爽电影| 两个人视频免费观看高清| 久久久欧美国产精品| 亚洲一级一片aⅴ在线观看| 别揉我奶头 嗯啊视频| 亚洲欧洲国产日韩| 亚洲av不卡在线观看| 亚洲欧美日韩无卡精品| 如何舔出高潮| 欧美日韩精品成人综合77777| 女人被狂操c到高潮| 日韩精品青青久久久久久| 精品人妻熟女av久视频| 久久久亚洲精品成人影院| 大香蕉97超碰在线| 亚洲精品aⅴ在线观看| 国产亚洲精品久久久com| 老司机影院毛片| 久久99热这里只频精品6学生| 国产午夜精品论理片| 久久久精品欧美日韩精品| 亚洲丝袜综合中文字幕| 2018国产大陆天天弄谢| a级一级毛片免费在线观看| 黄片无遮挡物在线观看| 插阴视频在线观看视频| kizo精华| 日日啪夜夜撸| 亚洲第一区二区三区不卡| 中文欧美无线码| 亚洲高清免费不卡视频| 日韩欧美一区视频在线观看 | 看十八女毛片水多多多| 亚洲熟女精品中文字幕| 能在线免费看毛片的网站| 日本一本二区三区精品| 国产乱人视频| 成人漫画全彩无遮挡| 啦啦啦啦在线视频资源| 最近中文字幕2019免费版| 久久综合国产亚洲精品| 亚洲不卡免费看| 三级国产精品欧美在线观看| 我要看日韩黄色一级片| 又黄又爽又刺激的免费视频.| 亚洲欧美精品专区久久| 亚洲欧美清纯卡通| 亚洲欧美成人精品一区二区| 免费播放大片免费观看视频在线观看| 美女cb高潮喷水在线观看| 久久久久免费精品人妻一区二区| 精品久久久久久电影网| 午夜激情福利司机影院| 国产av码专区亚洲av| 午夜福利在线观看吧| 国产毛片a区久久久久| 日日摸夜夜添夜夜爱| 国产精品.久久久| 最近中文字幕高清免费大全6| 久久久久久久久久成人| 日本av手机在线免费观看| 国产一区二区三区综合在线观看 | av免费在线看不卡| 日本一本二区三区精品| 777米奇影视久久| 成人欧美大片| 激情五月婷婷亚洲| 欧美日本视频| 女人十人毛片免费观看3o分钟| 亚洲欧美日韩东京热| 欧美性感艳星| 99re6热这里在线精品视频| av在线播放精品| 黄色一级大片看看| 六月丁香七月| 天堂中文最新版在线下载 | 国产精品伦人一区二区| 久久久久精品久久久久真实原创| 免费黄网站久久成人精品| 亚洲国产精品专区欧美| 一级爰片在线观看| 亚洲欧美中文字幕日韩二区| 午夜福利网站1000一区二区三区| 非洲黑人性xxxx精品又粗又长| 日韩欧美精品v在线| 成年免费大片在线观看| 亚洲成人中文字幕在线播放| 天堂影院成人在线观看| 国产欧美另类精品又又久久亚洲欧美| 日韩电影二区| 久久综合国产亚洲精品| 黄色一级大片看看| 久久久久九九精品影院| 国产成人精品久久久久久| 日本欧美国产在线视频| 国产女主播在线喷水免费视频网站 | 免费人成在线观看视频色| 精品久久国产蜜桃| 亚洲丝袜综合中文字幕| 偷拍熟女少妇极品色| 99久久九九国产精品国产免费| 毛片一级片免费看久久久久| 你懂的网址亚洲精品在线观看| 在线免费十八禁| 国产女主播在线喷水免费视频网站 | 精品不卡国产一区二区三区| 久久久久网色| 免费看a级黄色片| 久久久久久久国产电影| 国产 亚洲一区二区三区 | 丝袜喷水一区| 97在线视频观看| 久久久久免费精品人妻一区二区| 亚洲精品影视一区二区三区av| 国产女主播在线喷水免费视频网站 | 亚洲精品aⅴ在线观看| 久久综合国产亚洲精品| 乱系列少妇在线播放| 国产av码专区亚洲av| or卡值多少钱| 男女那种视频在线观看| 国产黄频视频在线观看| 插阴视频在线观看视频| 成人高潮视频无遮挡免费网站| 麻豆国产97在线/欧美| 久久人人爽人人片av| 久久久久久久久久久免费av| 2018国产大陆天天弄谢| 国产乱人偷精品视频| 亚洲av国产av综合av卡| 国产69精品久久久久777片| 亚洲成人精品中文字幕电影| 中文字幕制服av| 久久久久久伊人网av| 国产探花在线观看一区二区| 舔av片在线| 91狼人影院| 久久午夜福利片| 欧美日本视频| 校园人妻丝袜中文字幕| 免费av不卡在线播放| 久久久久网色| 边亲边吃奶的免费视频| 成人鲁丝片一二三区免费| www.色视频.com| 亚洲精品中文字幕在线视频 | 国产亚洲av嫩草精品影院| av网站免费在线观看视频 | 中文天堂在线官网| 干丝袜人妻中文字幕| 成人国产麻豆网| 蜜桃久久精品国产亚洲av| 国产国拍精品亚洲av在线观看| 国产又色又爽无遮挡免| 日日摸夜夜添夜夜爱| 三级国产精品欧美在线观看| 少妇人妻精品综合一区二区| 少妇被粗大猛烈的视频| 免费人成在线观看视频色| 欧美性猛交╳xxx乱大交人| h日本视频在线播放| 亚洲最大成人手机在线| 亚洲精品日韩在线中文字幕| 免费黄网站久久成人精品| 九色成人免费人妻av| 内射极品少妇av片p| 99久久精品国产国产毛片| 日韩精品青青久久久久久| 又爽又黄无遮挡网站| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 国产成人精品一,二区| 久久久精品欧美日韩精品| 国产白丝娇喘喷水9色精品| 午夜福利视频1000在线观看| 国产黄频视频在线观看| 日韩欧美国产在线观看| 国产精品日韩av在线免费观看| 欧美不卡视频在线免费观看| 禁无遮挡网站| 中文欧美无线码| 国产高清三级在线| 久久久精品欧美日韩精品| 人人妻人人澡人人爽人人夜夜 | 午夜福利在线观看免费完整高清在| 成人性生交大片免费视频hd| 3wmmmm亚洲av在线观看| 亚洲av成人精品一区久久| 激情 狠狠 欧美| 成人亚洲欧美一区二区av| 三级毛片av免费| 欧美bdsm另类| 波多野结衣巨乳人妻| 在线观看免费高清a一片| 午夜福利网站1000一区二区三区| 亚洲av电影不卡..在线观看| 国产精品国产三级国产av玫瑰| 午夜视频国产福利| 久久午夜福利片| 成人毛片a级毛片在线播放| 亚洲国产成人一精品久久久| 一边亲一边摸免费视频| 免费看光身美女| av女优亚洲男人天堂| 国产午夜精品久久久久久一区二区三区| 别揉我奶头 嗯啊视频| 国产视频首页在线观看| h日本视频在线播放| 国产精品熟女久久久久浪| av国产免费在线观看| 一级爰片在线观看| 日本av手机在线免费观看| 午夜福利网站1000一区二区三区| 婷婷色av中文字幕| 日韩欧美三级三区| 天天一区二区日本电影三级| 国产在视频线精品| 国产精品福利在线免费观看| 中文在线观看免费www的网站| 国产视频首页在线观看| 夜夜看夜夜爽夜夜摸| 三级国产精品片| 男女下面进入的视频免费午夜| 赤兔流量卡办理| 一个人观看的视频www高清免费观看| 1000部很黄的大片| 丝瓜视频免费看黄片| 中文精品一卡2卡3卡4更新| 国产伦理片在线播放av一区| 国产精品熟女久久久久浪| 91aial.com中文字幕在线观看| 国产高清三级在线| 亚洲精品久久午夜乱码| 寂寞人妻少妇视频99o| 国产91av在线免费观看| 一边亲一边摸免费视频| 九草在线视频观看| 非洲黑人性xxxx精品又粗又长| 亚洲美女视频黄频| 91狼人影院| 春色校园在线视频观看| 蜜臀久久99精品久久宅男| 亚洲在线自拍视频| 视频中文字幕在线观看| 日本-黄色视频高清免费观看| 中文字幕亚洲精品专区| 日韩av免费高清视频| 网址你懂的国产日韩在线| 国产精品美女特级片免费视频播放器| 久久久久精品久久久久真实原创| 免费av观看视频| 午夜福利视频1000在线观看| 哪个播放器可以免费观看大片| 久久久精品免费免费高清| 男女视频在线观看网站免费| 午夜日本视频在线| 乱码一卡2卡4卡精品| 偷拍熟女少妇极品色| 欧美精品一区二区大全| 国产91av在线免费观看| 99九九线精品视频在线观看视频| 你懂的网址亚洲精品在线观看| 极品教师在线视频| 丰满乱子伦码专区| 亚洲经典国产精华液单| 免费在线观看成人毛片| 国产亚洲91精品色在线| 天天一区二区日本电影三级| 在线免费观看不下载黄p国产| 99热网站在线观看| 国内精品一区二区在线观看|